60

Zhangzhou Pientzehuang Pharmaceutical Co LtdSHG 600436 Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Oct, 2024

Last price

Market cap $B

18.283

Large

Exchange

XSHG - Shanghai Stock Exchange

600436.SS Stock Analysis

60

Uncovered

Zhangzhou Pientzehuang Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

65/100

Moderate score

Market cap $B

18.283

Dividend yield

1.55 %

Shares outstanding

603.32 B

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese medicines. The company is headquartered in Zhangzhou, Fujian and currently employs 2,591 full-time employees. The company went IPO on 2003-06-16. The firm is also engaged in the production and sales of cosmetics and daily chemical products and the circulation of medicine. The firm's core products are PianZi Huang series products, including PianZi Huang, PianZi Huang capsule, compound PianZi Huang buccal tablets, compound PianZi Huang ointment, compound PianZi Huang hemorrhoids ointment and others, covering many fields such as liver disease medication, cold medication, dermatology medication. The firm's products are sold to domestic and overseas markets.

View Section: Eyestock Rating